Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Zercepac
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zercepac 150mg pdr for concentrate for inf vials
0801050ADBHAAAA
|
Zercepac | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Zercepac 420mg pdr for concentrate for inf vials
0801050ADBHACAE
|
Zercepac | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Zercepac 60mg pdr for concentrate for inf vials
0801050ADBHABAF
|
Zercepac | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.